Louis, C. U. & Shohet, J. M. Neuroblastoma: Molecular pathogenesis and therapy. Annu. Rev. Med. 66, 49–63 (2015).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Schleiermacher, G., Janoueix-Lerosey, I. & Delattre, O. Recent insights into the biology of neuroblastoma. Int. J. Cancer 135(10), 2249–2261 (2014).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Irwin, M. S. et al. Revised neuroblastoma risk classification system: A report from the Children’s Oncology Group. J. Clin. Oncol. 39(29), 3229–3241 (2021).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Park, J. R. et al. Effect of tandem autologous stem cell transplant vs single transplant on event-free survival in patients with high-risk neuroblastoma: A randomized clinical trial. JAMA. 322(8), 746–755 (2019).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Matthay, K. K. et al. Neuroblastoma. Nat. Rev. Dis. Primers 2, 16078 (2016).ArticleÂ
PubMedÂ
Google ScholarÂ
Halliwell, B. & Wasil, M. Tetracyclines as antioxidants in rheumatoid arthritis: Scavenging of hypochlorous acid. J. Rheumatol. 15(3), 530 (1988).CASÂ
PubMedÂ
Google ScholarÂ
Song, L. & Luo, Z. Q. Post-translational regulation of ubiquitin signaling. J. Cell Biol. 218(6), 1776–1786 (2019).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Weissman, A. M. Themes and variations on ubiquitylation. Nat. Rev. Mol. Cell Biol. 2(3), 169–178 (2001).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Ikeda, F. & Dikic, I. Atypical ubiquitin chains: new molecular signals. Protein modifications: Beyond the usual suspects’ review series. EMBO Rep. 9(6), 536–542 (2008).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Komander, D., Clague, M. J. & Urbe, S. Breaking the chains: Structure and function of the deubiquitinases. Nat. Rev. Mol. Cell Biol. 10(8), 550–563 (2009).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Muratani, M. & Tansey, W. P. How the ubiquitin-proteasome system controls transcription. Nat. Rev. Mol. Cell Biol. 4(3), 192–201 (2003).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Chen, L., Liu, S. & Tao, Y. Regulating tumor suppressor genes: Post-translational modifications. Signal Transduct. Target Ther. 5(1), 90 (2020).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Zhou, Y. et al. CCNB1IP1 prevents ubiquitination-mediated destabilization of MYCN and potentiates tumourigenesis of MYCN-amplificated neuroblastoma. Clin. Transl. Med. 13(7), e1328 (2023).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Dewson, G., Eichhorn, P. J. A. & Komander, D. Deubiquitinases in cancer. Nat. Rev. Cancer 23(12), 842–862 (2023).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Tavana, O. et al. HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma. Nat. Med. 22(10), 1180–1186 (2016).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Izumi, H. & Kaneko, Y. Trim32 facilitates degradation of MYCN on spindle poles and induces asymmetric cell division in human neuroblastoma cells. Cancer Res. 74(19), 5620–5630 (2014).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Becker, K., Marchenko, N. D., Maurice, M. & Moll, U. M. Hyperubiquitylation of wild-type p53 contributes to cytoplasmic sequestration in neuroblastoma. Cell Death Differ. 14(7), 1350–1360 (2007).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Yin, T. et al. An E3 ubiquitin-proteasome gene signature for predicting prognosis in patients with pancreatic cancer. Front. Immunol. 14, 1332626 (2023).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Zhang, J. et al. Ubiquitin-proteasome system-based signature to predict the prognosis and drug sensitivity of hepatocellular carcinoma. Front Pharmacol. 14, 1172908 (2023).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Luo, X. et al. Identification of a prognostic signature for ovarian cancer based on ubiquitin-related genes suggesting a potential role for FBXO9. Biomolecules. 13(12), 1724 (2023).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Tian, X. M. et al. A novel cuproptosis-related subtypes and gene signature associates with immunophenotype and predicts prognosis accurately in neuroblastoma. Front. Immunol. 13, 999849 (2022).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Shao, F. L., Liu, Q. Q. & Wang, S. Identify potential miRNA-mRNA regulatory networks contributing to high-risk neuroblastoma. Invest. New Drugs. 39(4), 901–913 (2021).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Shao, F., Wang, Z. & Wang, S. Identification of MYCN-related gene as a potential biomarker for neuroblastoma prognostic model by integrated analysis and quantitative real-time PCR. DNA Cell Biol. 40(2), 332–347 (2021).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Hartlieb, S. A. et al. Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome. Nat. Commun. 12(1), 1269 (2021).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Wang, C. et al. The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance. Nat. Biotechnol. 32(9), 926–932 (2014).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Wang, X. et al. UbiBrowser 2.0: A comprehensive resource for proteome-wide known and predicted ubiquitin ligase/deubiquitinase-substrate interactions in eukaryotic species. Nucleic Acids Res. 50(D1), D719–D728 (2022).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28(1), 27–30 (2000).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28(11), 1947–1951 (2019).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51(D1), D587–D592 (2023).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102(43), 15545–15550 (2005).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 27(12), 1739–1740 (2011).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013).ArticleÂ
ADSÂ
PubMedÂ
Google ScholarÂ
Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12(5), 453–457 (2015).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Racle, J., de Jonge, K., Baumgaertner, P., Speiser, D. E. & Gfeller, D. Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data. Elife. 6, e26476 (2017).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Chen, Y., Li, Z. Y., Zhou, G. Q. & Sun, Y. An Immune-Related Gene Prognostic Index for head and neck squamous cell carcinoma. Clin. Cancer Res. 27(1), 330–341 (2021).ArticleÂ
PubMedÂ
Google ScholarÂ
Su, Z. et al. An investigation of biomarkers derived from legacy microarray data for their utility in the RNA-seq era. Genome Biol. 15(12), 523 (2014).ArticleÂ
PubMedÂ
Google ScholarÂ
Iasonos, A., Schrag, D., Raj, G. V. & Panageas, K. S. How to build and interpret a nomogram for cancer prognosis. J. Clin. Oncol. 26(8), 1364–1370 (2008).ArticleÂ
PubMedÂ
Google ScholarÂ
Sun, L. et al. Substrate phosphorylation and feedback regulation in JFK-promoted p53 destabilization. J. Biol. Chem. 286(6), 4226–4235 (2011).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Pickart, C. M. & Eddins, M. J. Ubiquitin: Structures, functions, mechanisms. Biochim. Biophys. Acta 1695(1–3), 55–72 (2004).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Cervia, L. D. et al. A ubiquitination cascade regulating the integrated stress response and survival in carcinomas. Cancer Discov. 13(3), 766–795 (2023).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Li, H. et al. Secreted LRPAP1 binds and triggers IFNAR1 degradation to facilitate virus evasion from cellular innate immunity. Signal Transduct. Target Ther. 8(1), 374 (2023).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Lu, X. et al. UBE2M-mediated neddylation of TRIM21 regulates obesity-induced inflammation and metabolic disorders. Cell Metab. 35(8), 1390–405 e8 (2023).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Bedekovics, T. et al. USP24 is a cancer-associated ubiquitin hydrolase, novel tumor suppressor, and chromosome instability gene deleted in neuroblastoma. Cancer Res. 81(5), 1321–1331 (2021).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Gu, Y. et al. The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation. J. Exp. Clin. Cancer Res. 37(1), 258 (2018).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Meng, X., Li, H., Fang, E., Feng, J. & Zhao, X. Comparison of Stage 4 and Stage 4s neuroblastoma identifies autophagy-related gene and LncRNA signatures associated with prognosis. Front. Oncol. 10, 1411 (2020).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Hu, J. et al. Integrative analysis of multi-omics data for discovery of ferroptosis-related gene signature predicting immune activity in neuroblastoma. Front. Pharmacol. 14, 1162563 (2023).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Ma, K. et al. A signature based on five immune-related genes to predict the survival and immune characteristics of neuroblastoma. BMC Med. Genom. 15(1), 242 (2022).ArticleÂ
CASÂ
Google ScholarÂ
Ren, J. et al. Lupiwighteone induces cell cycle arrest and apoptosis and activates the Nrf2/ARE pathway in human neuroblastoma cells. Biomed. Pharmacother. 69, 153–161 (2015).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Filomeni, G., Piccirillo, S., Rotilio, G. & Ciriolo, M. R. p38(MAPK) and ERK1/2 dictate cell death/survival response to different pro-oxidant stimuli via p53 and Nrf2 in neuroblastoma cells SH-SY5Y. Biochem. Pharmacol. 83(10), 1349–1357 (2012).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Chen, W., Lin, P., Bai, J., Fang, Y. & Zhang, B. Establishment and validation of a nomogram to predict cancer-specific survival in pediatric neuroblastoma patients. Front. Pediatr. 11, 1105922 (2023).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Xu, S. et al. Association of the CD4(+)/CD8(+) ratio with response to PD-1 inhibitor-based combination therapy and dermatological toxicities in patients with advanced gastric and esophageal cancer. Int. Immunopharmacol. 123, 110642 (2023).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Duchemann, B. et al. CD8(+)PD-1(+) to CD4(+)PD-1(+) ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers. J. Immunother. Cancer 10(2), e004012 (2022).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Wu, S. Y., Fu, T., Jiang, Y. Z. & Shao, Z. M. Natural killer cells in cancer biology and therapy. Mol. Cancer 19(1), 120 (2020).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Cozar, B. et al. Tumor-infiltrating natural killer cells. Cancer Discov. 11(1), 34–44 (2021).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Skaar, J. R., Pagan, J. K. & Pagano, M. Mechanisms and function of substrate recruitment by F-box proteins. Nat. Rev. Mol. Cell Biol. 14(6), 369–381 (2013).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Jin, J. et al. Systematic analysis and nomenclature of mammalian F-box proteins. Genes Dev. 18(21), 2573–2580 (2004).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Veas-Perez de Tudela, M., Delgado-Esteban, M., Cuende, J., Bolanos, J. P. & Almeida, A. Human neuroblastoma cells with MYCN amplification are selectively resistant to oxidative stress by transcriptionally up-regulating glutamate cysteine ligase. J. Neurochem. 113(4), 819–825 (2010).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Zhang, W. et al. Comparative transcriptomic analysis of immune responses of the migratory locust, Locusta migratoria, to challenge by the fungal insect pathogen, Metarhizium acridum. BMC Genom. 16, 867 (2015).ArticleÂ
Google ScholarÂ
Teng, M. et al. A benchmark for RNA-seq quantification pipelines. Genome Biol. 17, 74 (2016).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Robert, C. & Watson, M. Errors in RNA-Seq quantification affect genes of relevance to human disease. Genome Biol. 16(1), 177 (2015).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Everaert, C. et al. Benchmarking of RNA-sequencing analysis workflows using whole-transcriptome RT-qPCR expression data. Sci. Rep. 7(1), 1559 (2017).ArticleÂ
ADSÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Pawlik, T. M. & Keyomarsi, K. Role of cell cycle in mediating sensitivity to radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 59(4), 928–942 (2004).ArticleÂ
PubMedÂ
Google ScholarÂ
Baskar, R., Dai, J., Wenlong, N., Yeo, R. & Yeoh, K. W. Biological response of cancer cells to radiation treatment. Front. Mol. Biosci. 1, 24 (2014).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Perez-Gonzalez, A., Bevant, K. & Blanpain, C. Cancer cell plasticity during tumor progression, metastasis and response to therapy. Nat. Cancer. 4(8), 1063–1082 (2023).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Liang, R. et al. Seleno-amino Acid metabolism reshapes the tumor microenvironment: From cytotoxicity to immunotherapy. Int. J. Biol. Sci. 20(7), 2779–2789 (2024).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Das, C. et al. A prismatic view of the epigenetic-metabolic regulatory axis in breast cancer therapy resistance. Oncogene 43, 1727 (2024).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ